SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000939767-16-000247
Filing Date
2016-09-26
Accepted
2016-09-26 17:28:51
Documents
2
Period of Report
2016-09-22

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_147492531805588.html 3  
1 FORM 3 wf-form3_147492531805588.xml 3 1665
2 POWER OF ATTORNEY (JULIE A. SMITH) smithpoa20160922.htm EX-24 3741
  Complete submission text file 0000939767-16-000247.txt   6985
Mailing Address 210 E. GRAND AVE SOUTH SAN FRANCISCO CA 94080
Business Address 210 E. GRAND AVE SOUTH SAN FRANCISCO CA 94080 6508377000
EXELIXIS, INC. (Issuer) CIK: 0000939767 (see all company filings)

IRS No.: 043257395 | State of Incorp.: DE | Fiscal Year End: 0102
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address C/O RAPTOR PHARMACEUTICAL CORP 9 COMMERCIAL BLVD, SUITE 200 NOVATO CA 94949
Business Address
Smith Julie (Reporting) CIK: 0001557928 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-30235 | Film No.: 161902979